These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6120845)

  • 1. Characterization of the beta-adrenergic inhibition of motility in cat colon strips.
    Ek B; Lundgren B
    Eur J Pharmacol; 1982 Jan; 77(1):25-31. PubMed ID: 6120845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic control of motility in the rat colon. I. Evidence for functional separation of the beta 1- and beta 2-adrenoceptor-mediated inhibition of colon activity.
    Ek BA; Bjellin LA; Lundgren BT
    Gastroenterology; 1986 Feb; 90(2):400-7. PubMed ID: 2867001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.
    Ek B
    Acta Physiol Scand Suppl; 1985; 546():1-39. PubMed ID: 2869641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic influence on esophageal and colonic motility in man.
    Lyrenäs E
    Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor interaction with full and partial beta-adrenoceptor agonists in the rat colon strip.
    Ek B
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):140-5. PubMed ID: 2897085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
    Hedberg A; Mattsson H; Nerme V; Carlsson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta 1- and beta 2-adrenoceptor-mediated secretion of amylase from incubated rat parotid gland.
    Carlsöö B; Danielsson A; Henriksson R
    Acta Physiol Scand; 1984 Mar; 120(3):429-35. PubMed ID: 6204505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical and practical problems with the assessment of intrinsic efficacy of agonists: efficacy of reputed beta-1 selective adrenoceptor agonists for beta-2 adrenoceptors.
    Kenakin TP
    J Pharmacol Exp Ther; 1982 Nov; 223(2):416-23. PubMed ID: 6127403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle.
    Manara L; Croci T; Aureggi G; Guagnini F; Maffrand JP; Le Fur G; Mukenge S; Ferla G
    Gut; 2000 Sep; 47(3):337-42. PubMed ID: 10940268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta 2-receptors in the rat anterior pituitary mediate adrenergic stimulation of prolactin release.
    Baes M; Denef C
    Life Sci; 1984 Apr; 34(15):1447-54. PubMed ID: 6143234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of beta-adrenergic stimulation to affect cholecystokinin-stimulated sigmoid motility in man.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1169-74. PubMed ID: 2869574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 1-adrenoceptor mediated salivary gland enlargement in the rat.
    Ekström J; Malmberg L
    Experientia; 1984 Aug; 40(8):862-3. PubMed ID: 6147266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related antipermeability effect of terbutaline and its inhibition by a selective beta 2-receptor blocking agent.
    Svensjö E; Roempke K
    Agents Actions; 1985 Mar; 16(1-2):19-20. PubMed ID: 2860793
    [No Abstract]   [Full Text] [Related]  

  • 20. Rectosigmoid motility response to beta-adrenoceptor stimulation in patients with the irritable bowel syndrome.
    Lyrenäs E; Abrahamsson H; Dotevall G
    Scand J Gastroenterol; 1985 Dec; 20(10):1163-8. PubMed ID: 2869573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.